CBARX
Price
$41.83
Change
-$1.55 (-3.57%)
Updated
Apr 4 closing price
Net Assets
1.34B
CLBFX
Price
$32.15
Change
-$1.22 (-3.66%)
Updated
Apr 4 closing price
Net Assets
220.57B
Ad is loading...

CBARX vs CLBFX

Header iconCBARX vs CLBFX Comparison
Open Charts CBARX vs CLBFXBanner chart's image
Calvert Balanced R6
Price$41.83
Change-$1.55 (-3.57%)
VolumeN/A
Net Assets1.34B
American Funds American Balanced 529F
Price$32.15
Change-$1.22 (-3.66%)
VolumeN/A
Net Assets220.57B
CBARX vs CLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBARX vs. CLBFX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBARX is a Hold and CLBFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 221B vs. CBARX (1.34B). CLBFX pays higher dividends than CBARX: CLBFX (2.14) vs CBARX (1.65). CBARX was incepted earlier than CLBFX: CBARX (6 years) vs CLBFX (23 years). CLBFX (0.68) is less costly to investors than CBARX (0.61). CLBFX is a more actively managed with annual turnover of: 171.00 vs. CBARX (153.00). CLBFX has a lower initial minimum investment than CBARX: CLBFX (250) vs CBARX (5000000). CBARX annual gain was more profitable for investors over the last year : 0.49 vs. CLBFX (-1.48). CBARX return over 5 years is better than : 48.79 vs. CLBFX (43.85).
CBARXCLBFXCBARX / CLBFX
Total Expense Ratio0.610.6890%
Annual Report Gross Expense Ratio0.610.6890%
Fund Existence6 years23 years-
Gain YTD-7.790-5.694137%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.34B221B1%
Annual Yield % from dividends1.652.1477%
Returns for 1 year0.49-1.48-33%
Returns for 3 years10.047.86128%
Returns for 5 years48.7943.85111%
Returns for 10 yearsN/A56.96-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.350.02
+0.86%
GT Biopharma
PRAX32.65-0.65
-1.95%
Praxis Precision Medicines
RPRX31.11-0.68
-2.14%
Royalty Pharma plc
KRRO14.38-0.37
-2.51%
Korro Bio
PTGX44.44-2.06
-4.43%
Protagonist Therapeutics